Australian Healthtech Stock News

ASX:SLX
ASX:SLXMachinery

Silex Systems (ASX:SLX): Evaluating Valuation After Laser Enrichment Tech Achieves Commercial-Scale Validation

Recent third-party validation of Silex Systems (ASX:SLX) laser-based uranium enrichment technology has sparked considerable market interest. The confirmation that it is now commercially ready and can help boost US uranium enrichment capacity has contributed to this attention. See our latest analysis for Silex Systems. The upbeat news around Silex Systems’ laser enrichment breakthrough has clearly sparked fresh excitement, sending its share price up nearly 48% over the last month and over 92%...
ASX:PAR
ASX:PARBiotechs

Can Paradigm Biopharmaceuticals' (ASX:PAR) Leadership Vision Drive Long-Term Strategic Value?

Paradigm Biopharmaceuticals Limited presented at the Ignite Investment Summit in Hong Kong on October 15, 2025, with Founder, MD & Executive Chairman Paul John Rennie delivering key insights. The company's participation at this high-profile investor event provided stakeholders with detailed updates on its strategic direction and executive leadership vision. We'll explore how Paradigm Biopharmaceuticals' focus on its executive leadership vision at the summit shapes its current investment...
ASX:PPT
ASX:PPTCapital Markets

Perpetual (ASX:PPT): Assessing Fair Value After Rising AUM and Wealth Business Sale Progress

Perpetual (ASX:PPT) saw total assets under management rise by 2.3%, even as net outflows and currency headwinds weighed on results. The company’s ongoing wealth business sale also remains in focus for investors. See our latest analysis for Perpetual. Despite resilient operating updates, Perpetual’s share price recently slipped to $19.30 after some short-term weakness, with a 7.7% drop over the past week that offset modest gains posted earlier in the month. Still, the longer-term total...
ASX:CIA
ASX:CIAMetals and Mining

3 Promising ASX Penny Stocks With Market Caps Below A$3B

The Australian market showed a mixed performance recently, with energy stocks leading the way due to geopolitical factors and materials remaining steady. In this context, penny stocks continue to attract attention for their potential to offer unique growth opportunities. Although the term "penny stocks" might seem outdated, these smaller or newer companies can still be promising investments when backed by strong financials and solid fundamentals.
ASX:BOT
ASX:BOTPharmaceuticals

Botanix Pharmaceuticals (ASX:BOT): Evaluating Valuation Following Leadership Changes, Product Rollouts, and Conference Updates

Botanix Pharmaceuticals (ASX:BOT) is drawing fresh attention this month as the company prepares for a major conference appearance, has updated investors on recent performance and product rollouts, and introduced a new joint company secretary to its leadership team. See our latest analysis for Botanix Pharmaceuticals. After a series of notable updates, including the appointment of a seasoned company secretary and an upcoming presentation at the Canaccord Genuity Drug & Device Conference,...
ASX:HUB
ASX:HUBCapital Markets

How Investors May Respond To HUB24 (ASX:HUB) Record Inflows and CEO Share Purchase

Earlier this week, HUB24 reported record quarterly net inflows of A$5.2 billion for Q1 FY26, pushing total funds under administration to A$146.5 billion as of September 30 and reflecting a 28% increase in inflows compared to the same period last year. An interesting development was the CEO’s recent significant share purchase, highlighting leadership confidence amid a rising share of retail users and new operational milestones. Let's examine how HUB24's exceptional inflows and funds under...
ASX:PAR
ASX:PARBiotechs

Paradigm Biopharmaceuticals (ASX:PAR): Assessing Valuation as Investor Focus Builds Ahead of Ignite Summit Presentation

Paradigm Biopharmaceuticals (ASX:PAR) is drawing increased attention ahead of its scheduled presentation at the Ignite Investment Summit in Hong Kong, where the company’s founder and executive team will address investors. See our latest analysis for Paradigm Biopharmaceuticals. After a year defined by volatility, Paradigm's share price has rebounded sharply with a 56% gain over the past month. This signals fresh momentum ahead of its summit appearance. While the short-term rally is grabbing...
ASX:SYL
ASX:SYLConstruction

Global Undervalued Small Caps With Insider Action In October 2025

As global markets navigate a volatile landscape marked by easing monetary policies from the U.S. Federal Reserve and fluctuating trade tensions, small-cap stocks have shown resilience, with indices like the Russell 2000 reflecting a notable year-to-date increase. In this environment, identifying promising small-cap opportunities involves looking for companies that demonstrate strong fundamentals and potential for growth amidst broader economic uncertainties.
ASX:WA1
ASX:WA1Metals and Mining

WA1 Resources (ASX:WA1) Is Down 9.2% After US–Australia Critical Minerals Pact—Has The Bull Case Changed?

Earlier this week, Prime Minister Anthony Albanese and US President Donald Trump announced a landmark US–Australia critical-minerals pact worth US$8.5 billion to advance key rare-earths projects and enhance bilateral government support for critical minerals supply chains. This high-profile international agreement highlights rising government interest in boosting domestic development for companies operating in Australia’s critical minerals sector, including WA1 Resources. We'll explore how...
ASX:SIQ
ASX:SIQProfessional Services

3 ASX Dividend Stocks Offering Yields Up To 6.1%

The Australian market has recently experienced a sell-heavy session, influenced by profit-taking and shifts in global economic sentiment, particularly around gold prices and US relations. In such an environment, dividend stocks can provide a stable income stream for investors seeking to weather market fluctuations, as they offer regular payouts that may help cushion against volatility.
ASX:WPR
ASX:WPRRetail REITs

Undervalued Small Caps With Insider Activity In Global For October 2025

As global markets navigate a volatile landscape marked by easing monetary policies and fluctuating trade tensions, small-cap stocks have shown resilience amid broader economic uncertainties. With the S&P 600 and Russell 2000 indices reflecting mixed performance, investors are keenly observing insider activity as a potential indicator of value within this segment. In such an environment, identifying small-cap stocks with strong fundamentals and strategic insider engagement can offer unique...
ASX:ASM
ASX:ASMMetals and Mining

Is Australian Strategic Materials' (ASX:ASM) Discounted Equity Raise a Strategic Bet or a Necessary Compromise?

Australian Strategic Materials recently completed a follow-on equity offering, raising A$55.16 million through the issuance of a total 45,967,502 new ordinary shares at A$1.20 per share, offered at discounts to prevailing market prices. This capital raise highlights the company's drive to secure funding for future projects while resulting in some dilution for existing shareholders. We’ll explore how this equity offering and the associated dilution may influence Australian Strategic...
ASX:MHJ
ASX:MHJSpecialty Retail

ASX Penny Stocks To Watch: Archer Materials And 2 More Promising Picks

As Australian shares face a dip, driven by a downturn in gold and other precious metals, investors are exploring diverse opportunities to navigate the shifting market landscape. Penny stocks, often associated with smaller or newer companies, present unique growth potential at lower price points despite their somewhat outdated label. In this article, we'll explore three penny stocks that stand out for their financial strength and potential for long-term success.